Answers are grounded in this paper and cite their sources.
Objective To compare the clinical characteristics of patients with Klebsiella pneumoniae liver abscess (KPLA) and non-KPLA patients, to describe the phenotype of invasive infection in patients with KPLA, and to develop and internally validate a simplified risk-classification model for identifying patients with invasive complications. Method A total of 300 patients with bacterial liver abscess were retrospectively included, including 246 cases of KPLA and 54 cases of non-KPLA. Categorical variables were compared using the χ 2 test or Fisher's exact test, and continuous variables were compared using the Mann–Whitney U test. With the occurrence of invasive infection in patients with KPLA as the outcome, a binary logistic regression model was constructed comprising three variables: maximum body temperature, lactate, and procalcitonin (PCT). Because peak values during hospitalization were used as predictors, the model was positioned as a cross-sectional risk-classification tool rather than a prospective prediction instrument. Internal validation was performed using 500 bootstrap resamples and repeated stratified 5-fold cross-validation for 50 iterations, and the model's discrimination, overall classification error, calibration, and decision curve performance were evaluated. Result KPLA accounted for 82.0% of all cases (246/300). Compared with non-KPLA patients, those with KPLA were younger, had a higher prevalence of diabetes, and had lower rates of malignancy, mixed infection, and any extrahepatic metastatic infection. The composite invasive outcome (bacteremia and/or extrahepatic metastatic infection) occurred in 46.7% (115/246) of KPLA patients, including 82 (33.3%) with bacteremia and 35 (14.2%) with extrahepatic metastatic infection (EMI). In the invasive group, the median PCT and lactate levels were 31.0 ng/mL and 2.40 mmol/L, respectively. In the non-invasive group, they were 1.50 ng/mL and 1.20 mmol/L, respectively. The differences between the two groups were statistically significant (both P < 0.001). In the final model, the adjusted ORs for highest body temperature, lactate, and PCT were 2.70 (95% CI 1.56–4.67), 2.77 (95% CI 1.52–5.07), and 1.10 (95% CI 1.06–1.14), respectively. Repeated cross-validation showed that the model achieved an AUC of 0.932 ± 0.003, a Brier score of 0.105 ± 0.002, and a calibration slope of 0.91 ± 0.04. Exploratory decision curve analysis suggested that the model may provide positive net benefit across the threshold range examined. Conclusion In this cohort, KPLA and non-KPLA differed in host background and clinical characteristics. A simplified three-variable risk-classification model incorporating maximum body temperature, lactate, and PCT demonstrated stable performance in internal validation for identifying patients with invasive complications (defined as bacteremia and/or extrahepatic metastatic infection). If validated prospectively, this model may facilitate early identification of high-risk patients who could benefit from intensified surveillance, timely adjustment of antimicrobial therapy, and proactive screening for extrahepatic metastatic foci. However, because peak values during hospitalization were used, a temporal relationship between predictors and outcome onset cannot be established, and the model should be interpreted as a cross-sectional risk-classification tool rather than a prospective prediction instrument. Its clinical applicability requires further investigation, including anchoring of predictor measurement to a standardized time point, harmonization of outcome definitions, and independent external validation in multi-center cohorts.
No takes yet. Share an insight, caveat, or question.
Bu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: